Eli Lilly (LLY) closed the most recent trading day at $1,027.51, moving +1.8% from the previous trading session. This change outpaced the S&P 500's 1.07% loss on the day. At the same time, the Dow ...

Eli Lilly and Company delivered best-in-class weight loss data for retatrutide, reinforcing its dominance in obesity and diabetes therapeutics. Retatrutide achieved up to 28.7% average weight loss and ...

Eli Lilly and Company (NYSE:LLY) is one of the best pharma stocks to invest in. On December 7, Eli Lilly and Company (NYSE:LLY) announced results from the Phase 3 BRUIN CLL-314 clinical trial that was ...

Dec 9 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S.

Eli Lilly (LLY) shares clocked seven straight sessions of losses on Friday, as the stock was 0.5% lower at $1,009.15. The pharmaceutical giant lost 8% in the preceding six sessions. Overall, the stock ...

The Steam Machine is the new PC gaming-focused console revealed by Valve in November 2025. Alongside this reveal, we also got our first look at the new Steam Controller and new VR headset, titled the ...

Eli Lilly LLY announced that it has lowered the price of single-dose vials of its blockbuster obesity drug, Zepbound (tirzepatide), purchased through the direct-to-consumer (DTC) platform LillyDirect.